Success Metrics

Clinical Success Rate
85.7%

Based on 6 completed trials

Completion Rate
86%(6/7)
Active Trials
0(0%)
Results Posted
33%(2 trials)
Terminated
1(13%)

Phase Distribution

Ph phase_1
2
25%
Ph phase_3
1
13%
Ph phase_2
5
63%

Phase Distribution

2

Early Stage

5

Mid Stage

1

Late Stage

Phase Distribution8 total trials
Phase 1Safety & dosage
2(25.0%)
Phase 2Efficacy & side effects
5(62.5%)
Phase 3Large-scale testing
1(12.5%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

85.7%

6 of 7 finished

Non-Completion Rate

14.3%

1 ended early

Currently Active

0

trials recruiting

Total Trials

8

all time

Status Distribution
Completed(6)
Terminated(1)
Other(1)

Detailed Status

Completed6
unknown1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
8
Active
0
Success Rate
85.7%
Most Advanced
Phase 3

Trials by Phase

Phase 12 (25.0%)
Phase 25 (62.5%)
Phase 31 (12.5%)

Trials by Status

completed675%
unknown113%
terminated113%

Recent Activity

0 active trials
Showing 5 of 8
terminatedphase_2

Trial of ZD1839 (Iressa) and Tamoxifen in Breast Cancer Patients

NCT00206492
completedphase_2

Radiotherapy,Chemotherapy,Before and After Surgery in Advanced Esophageal or Gastroesophageal Junction Cancer

NCT00258323
completedphase_2

ZD1839 (Iressa) for Recurrent or Metastatic Squamous Cell Carcinoma of the Skin

NCT00054691
completedphase_1

Cisplatin, Fluorouracil, Iressa, and Radiation Therapy Patients With Locally Advanced Head and Neck Cancer

NCT00352105
completedphase_2

Combination Casodex® and Iressa™ in Locally Advanced Prostate Cancer

NCT00319787
View all 8 trials

Clinical Trials (8)

Showing 8 of 8 trials
NCT00206492Phase 2

Trial of ZD1839 (Iressa) and Tamoxifen in Breast Cancer Patients

Terminated
NCT00258323Phase 2

Radiotherapy,Chemotherapy,Before and After Surgery in Advanced Esophageal or Gastroesophageal Junction Cancer

Completed
NCT00054691Phase 2

ZD1839 (Iressa) for Recurrent or Metastatic Squamous Cell Carcinoma of the Skin

Completed
NCT00352105Phase 1

Cisplatin, Fluorouracil, Iressa, and Radiation Therapy Patients With Locally Advanced Head and Neck Cancer

Completed
NCT00319787Phase 2

Combination Casodex® and Iressa™ in Locally Advanced Prostate Cancer

Completed
NCT00238628Phase 1

A Phase I/II Study of Bexarotene in Combination With ZD1839 (IRESSA®) in the Treatment of Non-Small Cell Lung Cancer

Completed
NCT01066195Phase 3

Pemetrexed (ALIMTA) and Gefitinib (IRESSA®) in Never-Smoker and Adenocarcinoma Patients With Non-Small Cell Lung Cancer Previously Treated With Platinum-Based Chemotherapy

Unknown
NCT00173875Phase 2

Iressa as a First-Line Treatment in Chemonaive Patients With Inoperable Non-Small Cell Lung Cancer

Completed

All 8 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
8